Jiangsu Libo Medicine Biotechnology Co., Ltd. is a technology-based enterprise dedicated to the research and development, production, and sales of blood typing diagnostic, tumor diagnostic, and related products.
The company aims to enhance its overall competitiveness by pursuing innovation, improving its product series, ensuring quality, and operating with integrity.
Our Company
The company is located at No. 78 Dongsheng West Road, Jiangyin City (inside the Jiangyin Yangtze River Biomedical Accelerator). Its registered capital is 35 million yuan, and total assets exceed 150 million yuan.
The company is continuously improving and perfecting its management systems so that all work has rules to follow; it has now established a complete quality management system and maintains its effective operation.
Our Team
Employees with a bachelor's degree or above account for approximately 75% of the total workforce; in addition, 8 experts in blood immunology have been specially engaged. *The team is led by professors and doctoral supervisors such as Lan Jiongcai and Feng Zhenqing, and consists of a number of doctoral and master's degree holders and other personnel with a bachelor's degree or above.
Our Policy
The company implements the quality policy of "regarding quality and integrity as the life of the company, and taking innovation and development as our eternal pursuit."
Our Platform
The company has 40,000 square meters of R&D, production, and office space.
It has respectively established R&D platforms for antibodies and detection reagents (cell engineering antibody R&D platform, genetic engineering antibody R&D platform, antibody pilot-scale platform), blood typing detection reagent and red blood cell detection reagent R&D bases, and master's/doctoral internship bases in cooperation with Nanjing Medical University, Yangzhou University, Beijing Red Cross Blood Research Institute, the Blood Center of the Beijing Military Region of the Chinese People's Liberation Army, Urumqi Blood Center, Jiangsu Province Blood Center, and other institutions.
The company has a fully equipped blood typing research laboratory, a Rare Antibody Detection Reagent Research Center of a Ministry of Health Key Laboratory, a white blood cell typing laboratory, a genetic engineering laboratory, a cell engineering laboratory, a cell identification laboratory, an animal laboratory, and a physical/chemical and microbiological testing laboratory.
Our Products
The company is mainly devoted to the R&D and production of products in the following areas:
(I) Human blood group serological diagnostic series: covering ABO blood typing test cards, ABO/RhD blood typing test cards, anti-human globulin crossmatching cards (anti-IgG), broad-spectrum anti-human globulin cards (anti-IgG+C3d), direct anti-human globulin reagent classification cards (IgG, C3d), ABO subtype detection cards, Rh blood typing cards, neonatal hemolytic disease detection cards, red blood cell typing reagents, irregular antibody screening reagents, rare antibody detection reagents, RHD gene homozygote/heterozygote identification kits, soluble HLA (sHLA) detection kits, etc.
(II) Tumor diagnosis: covering testing for nasopharyngeal carcinoma, rectal cancer, breast cancer, leukemia, autoimmune diseases, and other items.
Biotherapy: using monoclonal antibodies with tumor-specific recognition combined with tumor therapeutic drugs to construct monoclonal antibody-drug complexes for the treatment of tumor patients. (CD3, CD28, etc.)
(III) Cell culture: the company is equipped with a fully equipped cell culture seed bank and working bank, as well as a complete set of facilities and equipment required for red blood cell production.
Our Goal
Foreign* blood typing reagent manufacturers and the company have established cooperation platforms to jointly research and produce rare blood typing reagents within the company, which is expected to fill a domestic gap. In the coming years, the company will continuously increase R&D investment each year, gradually improve its blood typing detection reagent series, and strive to become a specialized supplier of reagents for blood typing diagnosis, tumor diagnosis, and biotherapy.
We will make every effort to contribute to the rise of the Chinese nation!
Contact phone: ***********
HR Department: Deng***: *********** (same number on WeChat)
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows